Latest Regulatory News

Page 218 of 632
Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.2182 per Capital Note 3 security, reflecting a 4.89% annualised yield tied to the 3-month BBSW plus margin.
Victor Sage
Victor Sage
22 Sept 2025
ADX Energy has secured a pivotal court ruling that allows it to resume drilling and testing at its Welchau-1 well in Austria, overcoming environmental objections and strengthening its exploration prospects.
Maxwell Dee
Maxwell Dee
22 Sept 2025
Thunderbird Resources has executed a binding agreement to acquire 100% of the Springfield Gold Deposit in NSW, a drill-ready project with significant historical gold intercepts. The company also secured $2.2 million in funding to kickstart exploration.
Maxwell Dee
Maxwell Dee
22 Sept 2025
Barton Gold Holdings has been added to the S&P Dow Jones ASX All Ordinaries Index, marking its rise among Australia's top 500 companies. The company is accelerating development of its South Australian gold projects, targeting significant production milestones by 2026.
Maxwell Dee
Maxwell Dee
22 Sept 2025
Starpharma has entered a significant collaboration with Genentech to develop dendrimer-drug conjugates for oncology, securing an upfront payment and potential milestone earnings exceeding half a billion dollars.
Ada Torres
Ada Torres
22 Sept 2025
Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.
Ada Torres
Ada Torres
22 Sept 2025
Resouro Strategic Metals has amended its private placement terms, aiming to raise CAD 3 million to fund engineering work for its Tiros Titanium-Rare Earths Project in Brazil.
Maxwell Dee
Maxwell Dee
22 Sept 2025
PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.
Ada Torres
Ada Torres
22 Sept 2025
LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.
Victor Sage
Victor Sage
22 Sept 2025
Ballard Mining reports strong infill drilling results at its Baldock gold deposit, confirming and refining a high-grade resource and targeting a maiden reserve by mid-2026. The ongoing program highlights potential resource growth beyond current estimates.
Maxwell Dee
Maxwell Dee
22 Sept 2025
Locksley Resources reports robust metallurgical testwork from its Mojave Project, confirming high antimony recoveries and concentrate grades that support a domestic US supply chain. The results align with US strategic priorities for critical mineral independence.
Maxwell Dee
Maxwell Dee
22 Sept 2025
Brightstar Resources has obtained key regulatory approvals for its Lord Byron open pit project, positioning the company to commence mining operations in the second half of 2026. This milestone advances Brightstar’s strategy to boost gold production from its Laverton Hub.
Maxwell Dee
Maxwell Dee
22 Sept 2025